bioRxiv Science⌕ Search

bioRxiv · 10.1101/569939

Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma

Abstract

Inflammation in the tumor microenvironment influences all stages of HCC development and progression as well as the anti-cancer response by immune system. In this study, we studied cytokine networks before and after transarterial chemotherapy (TACE). Serum samples obtained from 203 HCC patients treated with TACE were analyzed for inflammatory cytokines including interleukin (IL)-1{beta}, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12, IL-13, IL-17, IL-22, TNF-, IFN-{gamma}, and C-reactive protein (CRP) levels. Cytokine concentrations were measured at day 0 (D0, baseline), day3 (D3), day7 (D7), and day 60 (D60) after TACE. Network analysis revealed that modules within cytokine network at D0 were lost by D60 and modularity value (Mc) was decreased from 0.177 at D0 to -0.091 at D60. D60 had the lowest network heterogeneity and lower diameter, clustering coefficient, network density and recruited nodes. Degree correlation revealed that assortative network turned to disassortative network by D60 indicating that the network gained scale free feature. CRP, IL-2 were components of modules related with adverse outcome and IL-13, favorable outcome. Median survival month of patient group with high and low values with P-values were as follows: D0 CRP, 9.5 month (M), 54.2M (P<0.0001); D0 IL-2, 39.9M, 56.1M (P=0.0084); D3 CRP, 31.3M, 55.1 M (P=0.0056); D7 CRP, 28.7M, 50.7M (P=0.0065); IL-13, 51.9M, 33.6M (P=0.06). Network modularity decreased with temporal changes. Components of modules that included CRP, IL-2 and IL-6 were associated with adverse outcome and short overall survival. These modules were dissolved by D60 after TACE. Degree correlation decreased by D60, indicating that the cytokine network gained the scale free network property as in other biological network. TACE treatment converted cytokine network from that with inflammatory module to that with scale free network feature and without modules. Further studies are required to verify temporal changes of cytokine network in HCC patients after TACE.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

JEKARL, D. W., Lee, S., Kwon, J. H., Nam, S. W., Jang, J. W., Kim, M., Kim, Y.. 2019-03-06. Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma. https://doi.org/10.1101/569939

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Ksp37 is a rapidly mobilized NK cell secretory protein that engages FGF2

A key feature of natural killer (NK) cells is their preloaded arsenal of effector molecules, allowing them to rapidly respond upon activation. In this study, we characterized a previously unexplored secretory protein, termed killer-specific secretory protein of 37 kDa (Ksp37), which is highly abundant in differentiated CD56dim NK cells. Ksp37 is rapidly secreted in a dose-dependent and JAK-1 dependent manner upon low levels of cytokine stimulation, making it a sensitive readout for NK cell activation. Following secretion, intracellular levels were rapidly replenished, preserving responsiveness to subsequent cytokine stimulation. We found that Ksp37 is stored in polarized intracellular compartments distinct from those containing canonical cytotoxic effector molecules, including granzyme B and perforin, which require stronger stimulation for release. Lastly, we identified Ksp37 as a novel binding partner of fibroblast growth factor 2 (FGF2). This opens new avenues of exploration for the role of NK cells in remodeling their extracellular environment by modulating the FGF2-FGFR1 axis, which plays a key role in tumor growth, angiogenesis and tissue repair.

immunology↗

ACE-engineered human iPSC-derived neutrophils enhance host defense against multidrug-resistant bacterial infections

Severe neutropenia predisposes patients to life-threatening infections, while donor-dependent granulocyte transfusions are limited by availability and variable cell quality. Here, we engineered human induced pluripotent stem cells (iPSCs) to constitutively or inducibly express angiotensin-converting enzyme (ACE) and differentiated them into functional ACE-engineered neutrophils (ACE-iNeu). ACE expression enhanced granulocytic maturation, reactive oxygen species generation, inflammatory cytokine production, and antimicrobial signaling. ACE-iNeu exhibited enhanced bactericidal activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. Following adoptive transfer into neutropenic mice, ACE-iNeu significantly reduced circulating and tissue bacterial burdens. Integrated metabolomic and transcriptomic analyses revealed ACE-associated alterations in adenine nucleotide abundance and developmental and inflammatory pathways. Together, these findings establish ACE engineering as a strategy to enhance the production and antimicrobial function of human iPSC-derived neutrophils and support further preclinical development of engineered granulocyte therapies for severe drug-resistant infections.

immunology↗

Tetravalent dengue mRNA vaccination orchestrates balanced four-serotype immunity with durable memory and protection in mice.

An effective dengue vaccine must establish durable immunity across four dengue virus (DENV) serotypes, evade antibody-dependent enhancement (ADE), and overcome immune imprinting from prior exposure. Here, we developed TetprM-E mRNA-LNP, a tetravalent vaccine comprising LNP-formulated nucleoside-modified mRNAs encoding DENV1-4 precursor membrane-envelope (prM-E) antigens, and evaluated its immunogenicity, durability, protection and breath across serotype-specific immune backgrounds. Three immunization strategies elicited neutralizing titers greater than 1:1500 against each serotype. Passive transfer of immune sera conferred 100% survival and reduced viremia after lethal DENV2 challenge in immunocompromised mice. Vaccination induced DENV envelope (env)-specific CD8+T cells and CD4-dependent germinal-center responses. DENV env-binding antibodies persisted for 34 weeks alongside DENV env-specific memory B cells. Vaccine-elicited sera showed no measurable in vitro ADE. Although monovalent priming initially biased antibody responses, TetprM-E mRNA-LNP vaccination broadened neutralization across DENV1-4 regardless of priming serotype. Together, TetprM-E mRNA-LNP elicits broad, durable, and protective immunity despite serologic constraints from pre-existing immunity.

immunology↗